DRI Ask The Experts - Henry McCandless

Home

Who we are

Why we exist

In the news

The Experts speak
> Henry McCandless
>
> Arthur Schafer

Upcoming events

How to help

The Experts Speak

Citizen Audit of Responsibilities, Performance and Accountabilities in the Apotex Inc. Influence Issue at The University of Toronto's Hospital for Sick Children, 1996-1999.
- A Report by the Alliance for Public Accountability, February 2000.

	SUMMARY Main Message Summary Audit Observations Summary Recommendation General Observations Specific Recommendations

I. II. III. IV. V. VI. VII. VIII. IX. X. XI. XII. XIII.	THE REPORT Introduction to Citizen Audit Introduction to the APA report Purpose of the Report Who Had What Responsibilities and Accountabilities? Basic Principles and Concepts Used in the Report The precautionary principle The principle of directing-mind responsibility The principle of self-informing The principle of management control The concepts of responsibility and accountability The concept of public accountability What Happened at the Hospital Government policy affecting research The deferiprone (L1) research Warning signs Apotex's action The disclosure issue Hospital officials' and Board's response The Naimark consulting assignment January 1999 events Board of Trustees responsibilities, Performance and Answering Board of Trustees Responsibilities Board of Trustees Performance Board of Trustees Answering Hospital Executive Responsibilities, Performance and Answering Executive Responsibilities Executive Performance Executive Answering Senior Medical research Officials Responsibilities, Performance and Answering Research Officials Responsibilities Research Officials Performance Research Officials Answering Researchers Responsibilities, Performance and Answering Researchers Responsibilities Researchers Performance Researchers Answering University of Toronto Responsibilities, Performance and Answering University Responsibilities University Performance University Answering Health Protection Branch Responsibilities, Performance and Answering Health Protection Branch Responsibilities HPB responsibilities related to the Toronto Deferiprone trial Minister's responsibilities in funding and safety policy Health Protection Branch Performance HPB performance in safety-based policy for drugs HPB performance in the deferiprone trial Health Protection Branch Answering Medical Research Council Responsibilities, Performance and Answering Medical Research Council (MRC) Responsibilities MRC responsibilities in research funding policy MRC responsibilities in the deferiprone trial Medical Research Council Performance MRC performance in research funding policy MRC performance related to the Toronto clinical trial Medical Research Council Answering Apotex's Responsibilities, Performance and Answering Apotex's Responsibilities Apotex's Performance Apotex's Answering Epilogue: Events Subsequent to 25 January 1999 Hospital and University Officials' Actions The Harassment Mail Issue Statements Made in January-February 2000 Conclusion

	APPENDICES Appendix 1 Principles of Effective Governance Appendix 2 Observations on the Naimark Consulting Assignment Appendix 3 The University President's 25 January 1999 Agreement Appendix 4 Deferiprone in Europe in 1999